Evidence map›Paper›PMID 36829932›Full record

ReviewAntioxidants (Basel, Switzerland)2023

Oxidative Stress and Natural Antioxidants in Osteoporosis: Novel Preventive and Therapeutic Approaches.

Gemma Marcucci, Vladana Domazetovic, Chiara Nediani, Jessica Ruzzolini, Claudio Favre, Maria Luisa Brandi

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Antioxidants (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06866561 (The Effect of Aerobic Exercise on Bone Formation and Resorption Markers And The Quality of Life Tests in Postmenopausal Osteopenic Patients), which is not on this map. Cited by 94 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
94citing papers in PubMed, 3 pooled it
23.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06866561 nacompletednot on this map

The Effect of Aerobic Exercise on Bone Formation and Resorption Markers And The Quality of Life Tests in Postmenopausal Osteopenic Patients

TypeinterventionalSponsorBursa Yuksek Ihtisas Training and Research HospitalRan2022 to 2023Enrolled45ConditionsPostmenopausal OsteopeniaArmsaerobic exercise, cholecalciferol, calcium carbonate
3 · Its place in the literature

Who cites it

94 citing papers in PubMed, 3 syntheses or guidelines pooled it, 150 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. International journal of molecular sciences · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Acute and Subacute Oral Toxicity Evaluation ofFood science & nutrition · 2026
    Article
  19. Article
  20. Article

34 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Gemma MarcucciDepartment of Experimental and Clinical Biomedical Sciences, University of Florence, 50134 Florence, Italy.
Vladana DomazetovicDepartment of Paediatric Haematology-Oncology, Meyer Children's Hospital IRCCS, 50139 Florence, Italy.ORCID 0000-0001-8307-5662
Chiara NedianiDepartment of Experimental and Clinical Biomedical Sciences, University of Florence, 50134 Florence, Italy.ORCID 0000-0003-3190-3539
Jessica RuzzoliniDepartment of Experimental and Clinical Biomedical Sciences, University of Florence, 50134 Florence, Italy.
Claudio FavreDepartment of Paediatric Haematology-Oncology, Meyer Children's Hospital IRCCS, 50139 Florence, Italy.
Maria Luisa BrandiFIRMO Foundation, Via san Gallo 123, 50129 Florence, Italy.ORCID 0000-0002-8741-0592
University of Florence · ITMeyer Children's Hospital · ITFondazione FADOI · IT

Funding

Regione Toscana BIOSYNOL PSGO 52 2017
6 · The paper itself

Abstract

This review reports in detail the cellular and molecular mechanisms which regulate the bone remodeling process in relation to oxidative stress (OS), inflammatory factors, and estrogen deficiency. OS is considered an important pathogenic factor of osteoporosis, inducing osteocyte apoptosis and varying levels of specific factors, such as receptor activator κB ligand (RANKL), sclerostin, and, according to recent evidence, fibroblast growth factor 23, with consequent impairment of bone remodeling and high bone resorption. Bone loss increases the risk of fragility fractures, and the most commonly used treatments are antiresorptive drugs, followed by anabolic drugs or those with a double effect. In addition, recent data show that natural antioxidants contained in the diet are efficient in preventing and reducing the negative effects of OS on bone remodeling and osteocytes through the involvement of sirtuin type 1 enzyme. Indeed, osteocytes and some of their molecular factors are considered potential biological targets on which antioxidants can act to prevent and reduce bone loss, as well as to promote bone anabolic and regenerative processes by restoring physiological bone remodeling. Several data suggest including antioxidants in novel therapeutic approaches to develop better management strategies for the prevention and treatment of osteoporosis and OS-related bone diseases. In particular, anthocyanins, as well as resveratrol, lycopene, oleuropein, some vitamins, and thiol antioxidants, could have protective and therapeutic anti-osteoporotic effects.

Indexed as

bone remodelingestrogeninflammationnatural antioxidantsosteoblastsosteoclastsosteocytesosteoporosisoxidative stress

Identifiers

PMID36829932
PMCPMC9952369
OpenAlexW4319316240

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.